All Stories

UPDATE: US biotech Hookipa retracts merger plans with UK company

After announcing acquisition plans at the beginning of 2025, immunotherapeutics biotech Hookipa Pharma has decided not to buy rare disease company Poolbeg Pharma.

Feb 21, 2025 - 15:26
 0
UPDATE: US biotech Hookipa retracts merger plans with UK company
After announcing acquisition plans at the beginning of 2025, immunotherapeutics biotech Hookipa Pharma has decided not to buy rare disease company Poolbeg Pharma.
Read More

Tags:

Previous Article

Jeep Unveils New Limited Edition 2025 Wrangler 4xe Backcountry

Next Article

STAT+: Pharmalittle: We’re reading about RFK Jr. targeting CDC and FDA advisers,...

Related Posts

FDA clears first automated endoscope cleaning system with Nanosonics' CORIS

FDA clears first automated endoscope cleaning system wi...

Mar 27, 2025  0

Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate

Novartis inks $925M Anthos takeover to buy back phase 3...

Feb 11, 2025  0

Dexcom receives FDA warning letter over CGM manufacturing issues

Dexcom receives FDA warning letter over CGM manufacturi...

Mar 10, 2025  0